Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marylyn M Addo

Showing results (181-190 of 183) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 183 results.
The New England Journal of Medicine|April 2, 2015
Phase 1 Trials of rVSV Ebola Vaccine in Africa and EuropeSelidji T Agnandji, Angela Huttner, Madeleine E Zinser, et al.
Nature|May 6, 2016
Unique human immune signature of Ebola virus disease in GuineaPaula Ruibal, Lisa Oestereich, Anja Lüdtke, et al.
Science (New York, N.Y.)|November 6, 2010
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation, Florencia Pereyra, Xiaoming Jia, et al.
Pageof 19

Showing results (181-190 of 183) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 183 results.
The New England Journal of Medicine|April 2, 2015
Phase 1 Trials of rVSV Ebola Vaccine in Africa and EuropeSelidji T Agnandji, Angela Huttner, Madeleine E Zinser, et al.
Nature|May 6, 2016
Unique human immune signature of Ebola virus disease in GuineaPaula Ruibal, Lisa Oestereich, Anja Lüdtke, et al.
Science (New York, N.Y.)|November 6, 2010
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation, Florencia Pereyra, Xiaoming Jia, et al.
Pageof 19